Trinity Biotech ADR buy StockNews.com
Start price
02.12.23
/
50%
€0.45
Target price
02.12.24
-
Performance (%)
-4.93%
End price
03.12.24
-
Summary
This prediction is currently being closed. With a performance of -4.93%, the BUY prediction by StockNews_com is trending in the wrong direction. StockNews_com has a follow-up prediction for Trinity Biotech ADR, but this time predicts that Trinity Biotech ADR is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Trinity Biotech ADR | - | - | - |
| iShares Core DAX® | 4,64 % | 7,49 % | 6,99 % |
| iShares Nasdaq 100 | 4,47 % | 16,80 % | 40,28 % |
| iShares Nikkei 225® | 7,67 % | 16,86 % | 47,87 % |
| iShares S&P 500 | 2,47 % | 9,90 % | 28,43 % |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten